We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
On this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
